نتایج جستجو برای: pharmaceutical companies

تعداد نتایج: 139191  

2017
Rima Hajjar Aya Bassatne Mohamad Ali Cheaito Rabie Naser El Dine Sarah Traboulsy Fadi Haddadin Gladys Honein-AbouHaidar Elie A Akl

BACKGROUND Studies around the world have shown that interactions between pharmaceutical companies, pharmacists and physicians have a great influence on prescribing and drug dispensing practices. In middle-income countries, the nature and extent of these interactions have not been well researched. Our objectives were to qualitatively explore the nature of the interactions between pharmaceutical ...

Journal: :Therapeutic Innovation & Regulatory Science 2017

Journal: :International Journal of Environmental Science & Technology 2011

Journal: :Cold Spring Harbor Perspectives in Medicine 2014

Journal: :the iranian journal of pharmaceutical research 0
mehdi mohammadzadeh department of pharmacoeconomics and pharmacy management, school of pharmacy, shahid beheshti university of medical sciences. 14155-6153, tehran, iran. narges aryanpour department of pharmacoeconomics and pharmacy management, school of pharmacy, shahid beheshti university of medical sciences. 14155-6153, tehran, iran.

internationalization is a matter of committed decision-making that starts with export marketing, in which an organization tries to diagnose and use opportunities in target markets based on realistic evaluation of internal strengths and weaknesses with analysis of macro and microenvironments in order to gain presence in other countries. a developed model for export and international marketing of...

This study aims to measure the production capacity and capacity utilization in pharmaceutical industry. The capacity utilization is the ratio of actual production level to the potential production level which shows the gap between real production and production capacity. Method: Through econometric methods, the short-run translog cost function is estimated with the cost share function of produ...

Journal: :Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku 1999

Journal: :Drug discovery today 2009
Esther F Schmid Rebecca Ashkenazy James Merson Dennis A Smith

Healthcare costs in all industrial nations have increased and payors are starting to look at new ways to contain costs and at new funding models. The business model of pharmaceutical companies is also undergoing rapid changes - potentially disruptive new modalities, such as RNAi, therapeutic vaccines, and cell therapy are emerging, R&D costs have increased year on year, pressures on drug pricin...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید